STAT - Reporting from the frontiers of health and medicine

Don't Miss

By STAT staff

Health

Politics

Biotech Bayer to buy gene therapy company AskBio for as much as $4 billion
The Pharmalot View ‘Where is Rudy?’: Inside Giuliani’s checkered track record as a pharma consultant
First Opinion I have all the symptoms of a Covid-19 long-hauler — but I’m hesitant to identify myself as one
Health Tech Bias, consent, and data transparency: What patients want the FDA to consider about AI in medicine
Health Tech 8 leading names in digital health weigh in on the biggest barriers facing the industry

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Health Canada releases final version of controversial regulations for controlling drug prices
Foghorn Therapeutics raises $120 million in IPO
Pharmalittle: A Covid-19 vaccine induced immune response in older people; Covid-19 insiders sold lots of stock

A STAT Investigation

Special Report

Health

By Gabrielle Glaser

Health

By Amy Sokolow

Heavyweights

Politics

Health The Covid-19 Tracker
Health CDC expands definition of ‘close contacts,’ after study suggests Covid-19 can be passed in brief interactions
Health FDA shows signs of cold feet over emergency authorization of Covid-19 vaccines
Don't Miss As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies
Health Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart
Biotech Bayer to buy gene therapy company AskBio for as much as $4 billion
The Pharmalot View ‘Where is Rudy?’: Inside Giuliani’s checkered track record as a pharma consultant
Health Watch: mRNA vaccines face their first test in the fight against Covid-19. How do they work?